Author

Roxana Ola

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Ancuta Jurj· 1 shared Ciprian Tomuleasa· 1 shared Cristina Selicean· 1 shared Gabriel Ghiaur· 1 shared Grigore GafencuiD· 1 shared Ioana Berindan-Neagoe· 1 shared Lorand Magdo· 1 shared Valentina PileczkiiD· 1 shared

Activity by Year

2018-2018 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ancuta Jurj

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

DNMT3A-NPM1 mutated acute myeloid leukaemia shows sensitivity to a PARP1 inhibitor combined with daunorubicin in an in vitro model

Grigore Gafencu, Valentina Pileczki, Ancuta Jurj, Lorand Magdo, Cristina Selicean, Roxana Ola, Gabriel Ghiaur, Ioana Berindan-Neagoe, Ciprian Tomuleasa

The paper tests if PARP inhibitors combined with anthracyclines are effective against DNMT3A-NPM1 mutated AML in vitro, finding similar sensitivity to MLL-AF9 mutated leukaemias.

bioRxiv · Jul 5, 2018 · PreprintCancer Biology